VEGF-B Gene Transfer Increases Retinal and Choroidal Neovascularization
Author Information
Author(s): Zhong Xiufeng, Huang Hu, Shen Jikui, Zacchigna Serena, Zentilin Lorena, Giacca Mauro, Vinores Stanley A.
Primary Institution: Wilmer Eye Institute, Johns Hopkins University School of Medicine
Hypothesis
The study evaluates the effect of overexpression of VEGF-B via gene transfer on ocular angiogenesis, inflammation, and the blood-retinal barrier.
Conclusion
VEGF-B overexpression promotes pathological retinal and choroidal neovascularization and blood-retinal barrier breakdown without causing inflammation.
Supporting Evidence
- VEGF-B167 and VEGF-B186 increased retinal and choroidal neovascularization.
- VEGF-B186 significantly increased retinal vascular permeability.
- There was no evidence of an inflammatory response following the gene transfer.
- VEGF-B targeting could benefit antiangiogenic therapy.
Takeaway
The study found that increasing a protein called VEGF-B in the eye can lead to more abnormal blood vessel growth without causing inflammation, which is important for understanding eye diseases.
Methodology
The study used adeno-associated virus vectors to deliver VEGF-B genes to mice and assessed the effects on neovascularization and blood-retinal barrier integrity.
Participant Demographics
C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website